EOLS - Survey finds GLP-1 users more inclined to get aesthetic procedures
2024-03-17 17:09:16 ET
More on AbbVie, Evolus, etc.
- AbbVie Inc. (ABBV) Barclays 26th Annual Global Healthcare Conference (Transcript)
- AbbVie: Comeback Expected After Humira Patent Expiration
- AbbVie Stock: I Was So Wrong, But This Is Way Too Fast
- Evolus prices stock offering to raise about $50M
- Revance stock rises after CEO discloses share purchase